Trial Search Results

Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast

To determine the ability of magnetic resonance lymphangiography using conventional gadolinium injected directly into the tumor site and PET scan in detecting microscopic nodal metastasis in patients with newly diagnosed H&N cancers

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Intervention(s):

  • Procedure: IMR LAG

Phase:

N/A

Eligibility


Inclusion Criteria:Patients with newly diagnosed squamous cell carcinomas of the H&N with
primary tumor sites that are accessible to direct contrast injections

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Bill Loo
6507367143
Not Recruiting